Outcome following acute myocardial infarction: Are differences among physician specialties the result of quality of care or case mix?

Archives of Internal Medicine

Volumn 159, Issue 13, 1999, Pages 1429-1436

  Frances, Craig D ^a,c   Go, Alan S ^a   Dauterman, Kent W ^a   Deosaransingh, Kamala ^b   Jung, Dexter L ^b   Gettner, Sharmeen ^b   Newman, Jeff M ^b   Massie, Barry M ^a   Browner, Warren S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Medical Review Inc   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CALIFORNIA; CARDIOLOGY SERVICE, HOSPITAL; DIAGNOSIS-RELATED GROUPS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MEDICAL RECORDS; MEDICARE PART A; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SPECIALTIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 0033549592     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.13.1429     Document Type: Article

References (39)

1. American Heart Association. 1990 Heart Facts. Dallas, Tex: American Heart Association National Center; 1992.
2. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction: The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993;328: 685-691.
3. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673-679.
4. Grines CL. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? primary angioplasty - the strategy of choice. N Engl J Med. 1996;335:1313-1317.
5. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? a quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476-485.
6. Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction: Alabama Registry of Myocardial Ischemia Investigators. Am J Cardiol. 1994; 74:111-118.
7. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
8. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
9. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2: 349-360.
10. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841-2847.
11. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction: mortality. Am J Cardiol. 1985;56:15G-22G.
12. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
13. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
14. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation. 1995;92:3132-3137.
15. The Israeli Sprint Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J. 1988;9:354-364.
16. Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984;69:740-747.
17. Sirnes PA, Overskeid K, Pedersen TR, et al. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. Circulation. 1984;70:638-644.
18. Wilcox RG, Hampton JR, Banks DC, et al. Trial of early nifedipine in acute myocardial infarction: the Trent study. BMJ. 1986;293:1204-1208.
19. Gunnar RM, Passamani ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol. 1990; 16:249-292.
20. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 1996;28:1328-1428.
21. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol. 1995;26:1432-1436.
22. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
23. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331:1136-1142.
24. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996; 335:1880-1887.
25. Ayanian JZ, Guadagnoli E, McNeil BJ, Cleary PD. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 1997;157:2570-2576.
26. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
27. Normand ST, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA. 1996;275: 1322-1328.
28. SAS release 6.11. Cary, NC: SAS Institute; 1996.
29. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130-1135.
30. Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med. 1996;335:1888-1896.
31. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333:573-578.
32. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570.
33. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320:53-56.
34. Blumenthal D. Quality of health care, part IV: the origins of the quality-of-care debate. N Engl JM ed. 1996;335:1146-1149.
35. Brook RH, McGlynn EA, Cleary PD. Quality of health care, part II: measuring quality of care. N Engl J Med. 1996;335:966-970.
36. Kritchevsky SB, Simmons BP. Continuous quality improvement: concepts and applications for physician care. JAMA. 1991;266:1817-1823.
37. Laffel G, Blumenthal D. The case for using industrial quality management science in health care organizations. JAMA. 1989;262:2869-2873.
38. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351-1357.
39. Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA. 1998;279:1358-1363.